Found 7 matching trials
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors PHASE2 This study aims to evaluate the efficacy and safety of QLS31905 and/or QL17...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma PHASE2 This is an open-label, multicenter Phase II clinical study aimed at evaluat...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination of QLS31905 and Chemotherapy ยฑ QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer PHASE2 This is an open-label, multicenter Phase II clinical study aimed at evaluat...
Show More Location
Multiple Locations
Learn More & Join Trial
QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ PHASE3 This study is a randomized, open, multicenter phase III clinical study desi...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of QLS31905 in Patients With Advanced Solid Tumors PHASE1 This is a multi-center, open-label design to evaluate the safety and tolera...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors PHASE1 This study aims to evaluate the efficacy and safety of QLS31905 plus chemot...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer PHASE3 The goal of this study is to evaluate the efficacy of QLS31905 in combinati...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial